Today, February 4th 2022, is the 21st World Cancer Day. This international day is intended to provide information about cancer prevention options and current developments in the fields of diagnosis, therapy and aftercare.
Pharmacelsus, a company of the GBA Group Pharma, accompanies research and drug development. For more than 20 years, we have been planning, organizing and implementing customer-specific preclinical studies. Our biomarker services help to predict bioactivity, efficacy and adverse reactions of the lead compound in the early development phase and, thus, allow the selection of only promising drug candidates for the clinical phase. This is how we contribute to drug discovery and cancer therapy.